Satellite images are highlighting China’s death surge, showing an uptick in the number of vehicles parked at funeral homes.
A Pfizer-made COVID-19 drug is soon to be removed from China’s health insurance list. Beijing is complaining the drug is “too expensive,” while the drugmaker’s CEO disagrees.
Bipartisan efforts are workin...